Getting the Most Out of TLM: A Discussion for Hepatology Associates by Hepatology Associates (Live)

Create Account

Availability

Registration Required

https://aasld.zoom.us/j/89715365712

Oct 14, 2025 12:00 PM - 1:00 PM ET

Cost

$0.00

Credit Offered

No Credit Offered

Description
Learning Objectives
Faculty
Privacy Policy

Hepatology Associates, especially those early in their careers, report uncertainty about how to navigate large national meetings like TLM (e.g., how to choose sessions, network, and plan effectively). This activity will offer a structured support and peer-to-peer mentoring opportunity around professional development and national meeting engagement. Hepatology associates from AASLD have requested a strong interest in discussions related to obtaining professional development, networking, and conference preparation. This activity will offer ways to better support the transition from trainee to active participant at national meetings. Peer-reviewed literature on early-career engagement in specialty conferences (e.g., JAMA, Hepatology Communications) underscores the value of mentorship and structured guidance for maximizing educational and career-building opportunities.

This activity will be applicable for nurses, nurse practitioners, pharmacists, physician assistants, transplant coordinators and others who are first time attendees to The Liver Meeting 2025 (TLM).

This activity will not offer CE Credits.

COPYRIGHT: All faculty in this activity have given their permission for publication ©2025 AASLD.

Upon completion of this activity, participants should be able to:

• Describe at least two practical strategies for navigating The Liver Meeting (TLM) as a first-time or early-career attendee.
• Identify key opportunities and approaches to engage with mentors, peers, and professional development resources at TLM
• Demonstrate increased confidence in participating in TLM sessions, networking events, and poster presentations, as measured by post- session self-assessment

This online educational activity has been planned in accordance with the AASLD Financial Disclosure Policy and ACCME Standards for the Integrity and Independence for Accredited Continuing Education by members of the AASLD Transplant Hepatology Board Review Course faculty, the AASLD Maintenance of Certification Committee and the AASLD Governing Board. As an accredited provider, AASLD must collect information from all planners, faculty and others in the planning and control of continuing medical education (CME) activities to disclose all of their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, in ineligible companies. Individuals must disclose financial relationships with ineligible companies regardless of their view of the relevance of the relationship to the education. The American Association for the Study of Liver Diseases (AASLD) has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair balanced, independent, and free of commercial bias. Conflicts, if any, are resolved through one or more processes. All relevant conflicts pertaining to this activity have been mitigated. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of AASLD. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Hazel Domingo, MMSc, PA-C

Dawn Drazek, MSN, NP, A-GPCNP-BC, AF-AASLD

Janet Gripshover, DNP, MBA, FNP-BC, AF-AASLD

PRIVACY POLICY: https://www.aasld.org/terms-use-and-privacy-policy